Castuner

Cognitio

LifeSciences Australia

Welcome to Cognitio, the weekly podcast by LifeSciences Australia, your go-to source for insights into the evolving world of medtech, pharmaceuticals, and life sciences. Hosted by Dr Tim Boyle, this podcast delivers bite-sized updates, expert discussions, and professional development insights to keep you informed and ahead of the curve.Each episode features hot topics, regulatory updates, sector trends, and practical career guidance, with guest appearances from industry leaders, ARCS members, and emerging innovators from BioBeacon. Whether you're a seasoned professional or just starting

Сайт подкаста

Слушайте в своём приложении

Эпизоды

67 эпизодов

  1. Taking Control of Your Own Development, with Rod Matthews 21:32
  2. Behind the Scenes: Running a Global Pharmacovigilance System 21:43
  3. What AI Can’t Do (Yet): An Honest Gap Analysis for Regulatory Professionals 20:41
  4. Enabling Leadership with Zak Huang 49:41
  5. Making Safety Part of Drug Design 46:19
  6. Navigating Complexity: Multi-Site Governance and AI in Research Oversight 25:47
  7. Between Leadership and Dependence: Australia's HTA System Under Pressure 31:04
  8. What the Coroners Know 34:34
  9. Draw It Before You Say It 33:59
  10. How Do We Know It Isn't Just Luck? Biostatistics in Early Phase Trials 29:52
  11. Invisible, Essential and Overloaded: Rethinking Medical Operations 30:10
  12. Adoption of AI in Pharmacovigilance 31:29
  13. Bringing Clinical Trials Closer to Home: Building a Regional Trial Service 29:40
  14. From Discovery to Patient Impact: Perseverance, Integrity and the Path to Innovation 13:59
  15. Paul Batten, ObjectivoData 21:10
  16. Dr Daniel Beard, Founder and CSO ShearFlow 26:39
  17. AI Basics for Regulatory Professionals: Safe Use, Smart Prompting and Human Accountability 38:52
  18. ARCS Weekly Wrap - 1 May 2026 1:31
  19. Signals to Clinical Evidence 29:03
  20. S02E10 High Performance, Hidden Challenges 43:32
  21. Teams First: Cultivating Resilient Leaders in Competitive Environments 39:09
  22. Designing with, not for: The Power of Patient Co-Creation 30:26
  23. Reimbursement Pathways and Patient Access for Cell and Gene Therapies in Australia 39:59
  24. ARCS Weekly Wrap 20 March 2026 2:35
  25. Regulatory Guidelines Supporting Non-Animal Models in Pharmaceutical Development 36:09
  26. Why do smart professionals still freeze in high-pressure moments? 29:40
  27. From Trial to Market: Navigating Pharmacovigilance Case Management Differences 11:55
  28. ARCS Weekly Wrap 27 February 2026 2:49
  29. Cell & Gene Therapy in Australia: Are We Ready? 11:20
  30. South Korea: An Emerging Powerhouse in Clinical Trials and Pharmacovigilance 23:58
  31. ARCS Weekly Wrap 13 February 2026 2:45
  32. Advancing LGBTQIA+ Inclusion in Healthcare 40:12
  33. ARCS Weekly Wrap 6 February 2026 2:55
  34. ARCS Weekly Wrap 5th December 2025 8:14
  35. Yarning Up Research: shifting from “done to” to “done with” in Aboriginal health trials 32:38
  36. ARCS Weekly Wrap 28 November 2025 11:44
  37. Heart of Australia 43:18
  38. ARCS Weekly Wrap 21 November 2025 8:27
  39. Pharmacovigilance and Equity: Medicine Safety for First Nations Communities 30:41
  40. ARCS Weekly Wrap 14 November 2025 9:45
  41. What is Intellectual Property? 50:07
  42. ARCS Weekly Wrap 7th November 2025 8:51
  43. AI in Regulatory Affairs: From Burden to Breakthrough 29:12
  44. Next Generation Nuclear Medicine 43:57
  45. ARCS Weekly Wrap 26 September 2025 6:36
  46. Market Access - Devices vs Medicines 25:02
  47. ARCS Weekly Wrap 19 September 2026 5:41
  48. Unpacking the R&D Tax Incentive for the Australian LifeSciences sector 22:32
  49. ARCS Weekly Wrap 12 September 2025 5:16
  50. Navigating the Regulatory Landscape of In Vitro Diagnostics 24:51